Dilemmas in periocular and orbital tumour management - update
The 2026 Dilemmas in periocular and orbital tumour management course will take place on 7 July 2026.
Dilemmas in periocular and orbital tumour management
This year's update focuses on the management of periocular and ocular surface malignancies — melanoma, squamous cell carcinoma, sebaceous carcinoma and basal cell carcinoma — alongside a look ahead at the future of cancer diagnostics and therapeutics in our field.
Course aims
- Update on the management of periocular and ocular surface melanoma, including primary acquired melanosis, lentigo maligna, cutaneous, conjunctival and uveal melanoma, with a focus on neoadjuvant therapies and current research.
- Update on the management of ocular surface squamous neoplasia, locally advanced invasive squamous cell carcinoma, and sebaceous cell carcinoma.
- Update on the management of locally advanced basal cell carcinomas, including the role of targeted therapy and immunotherapy.
- Insights into future developments in oncology, including the tumour microenvironment, liquid biopsies and circulating tumour DNA, IBEX imaging, and current clinical trials in the UK.
Course structure
Dilemmas in periocular and orbital tumour management is an international collaboration between Moorfields Eye Hospital, London, and MD Anderson Cancer Center, Houston, bringing you the latest research and practice in periocular and orbital oncology.
The course features a full day of lectures, case discussions and panel debate, delivered by leading speakers and chaired by Miss Claire Daniel, Ocular Oncology Lead and Adnexal Service Director at Moorfields Eye Hospital, London, UK; world-renowned Professor Bita Esmaeli, Professor of Orbital and Ocular Oncology at MD Anderson Cancer Center, Houston, USA; and Mr Sachin Salvi, Clinical Lead of the Sheffield Ocular Oncology Service and Orbital and Oculoplastic Surgery Services, Sheffield Hospital, UK.
The day is structured around four sessions: Melanoma; Squamous Cell Carcinoma and Sebaceous Carcinoma; Basal Cell Carcinoma; and Future Developments in Oncology. Each session combines didactic lectures with illustrative cases and interactive discussion.
You will have the option to attend in person at our training centre in Ebenezer Street, London N1, or online.
Please note that, while the course will be recorded for CPD purposes, we will not be able to share all lectures with attendees. You will need to be able to attend on the day in order to see all sessions.
Who should attend
- Ophthalmologists with sub-specialist interest in oncology, adnexal and oculoplastic.
- Oncologists - clinical & radiological.
- Radiologists with sub-specialist interest in head and neck imaging/cancer.
- Dermatologists and skin cancer multidisciplinary team members with an interest in periocular tumours.
- Suitable for consultants, senior registrars, fellows and allied health care professionals.
This day is free of charge for Moorfields Adnexal Fellows; please email moorfields.courses@nhs.net from your Moorfields email address to receive a code to book.
Accreditation
CPD certified. A certificate of attendance will be awarded at the end of the course.
Requirement
In order to join the course online, you will need access to a computer (laptop or desktop) with a webcam and microphone.
Booking your place - important, please read before booking your place
Please ensure that you add the correct item to your cart from the options below, depending on your role and whether you wish to attend in-person or online.
In-person places are restricted to a maximum of 50 people due to venue capacity. Once these places are filled it will only be possible to attend online.
Book Now
| Date | Location | Time | Seats | Price | |
| 7 July 2026 | In person at The Education Hub, 15 Ebenezer Street, London, N1 7NH | In-person - Consultant ophthalmologist | £250.00 | ||
| 7 July 2026 | In person at The Education Hub, 15 Ebenezer Street, London, N1 7NH | In-person - Trainee/Fellow/Allied healthcare professional | £130.00 | ||
| 7 July 2026 | Online via MS Teams | Online - Consultant ophthalmologist | £250.00 | ||
| 7 July 2026 | Online via MS Teams | Online - Trainee/Fellow/Allied healthcare professional | £80.00 |
Course fees
Location
Taught by
Claire Daniel
Miss Claire Daniel is a Consultant Ophthalmic Surgeon at Moorfields Eye Hospital, London. She specializes in Oculoplastic Surgery, Periocular Dermatology and Lid Oncology. She is the lead for eyelid oncology at Moorfields Eye Hospital and has over 20 years of experience of working at Moorfields. She also holds an Honorary Consultant contract at Guys and St Thomas' Hospital, London with the Head and Neck Department. Miss Daniel is the Trust Multiple Disciplinary Team Lead for Moorfields with the dermatology, melanoma and head and neck team at Guys & St Thomas' Hospital. She receives specialist referrals from units around the UK. Miss Daniel trained at Guy's and St Thomas' Medical School in London and qualified as a Doctor in 1994, after achieving a First Class Honours Batchelor of Science Degree. She trained at Moorfields Eye Hospital, London and has worked at the world famous eye hospital for over 20 years and became a Fellow of the Royal College of Ophthalmologists in 1999. In her current post as a Consultant Ophthalmic Surgeon in the Adnexal Department at Moorfields she performs corrections of lid malpositions such as ptosis, entropion or ectropion, and reconstruction surgery after trauma or removal of periocular tumours. She also performs surgery for watery eyes and lacrimal drainage problems. Miss Daniel reconstructs ophthalmic socket problems and corrects socket lining abnormalities. Miss Daniel is responsible for training doctors in oculoplastic surgery at Moorfields. She teaches doctors, optometrists and nurse practitioners and general practitioners about how to recognise and manage eye problems. She is the chair for an on-going training programme for specialist surgeons in Oculoplastics in collaboration with Professor Bita Esmaeli at the MD Anderson Cancer Center in Houston. USA. She has presented her work at International and National Ophthalmic Conferences and has published peer reviewed papers in international journals and several book chapters in ophthalmic education.
Bita Esmaeli
Internationally renowned for her expertise in orbital oncology and oncologic ophthalmic plastic surgery, Dr. Bita Esmaeli is a professor and the Fellowship Program Director for Ophthalmic Plastic Surgery in the Department of Plastic Surgery at The University of Texas MD Anderson Cancer Center in Houston, Texas. Board-certified by the American Board of Ophthalmology, her practice focuses on the surgical treatment of orbital tumors, lacrimal gland carcinomas, eyelid cancers, melanoma of eyelid and conjunctiva, and reconstructive surgery in the periocular region including lacrimal surgery. Dr. Esmaeli has authored over 300 publications and has spearheaded numerous clinical trials and research protocols. Additionally, she teaches throughout the world and is a frequent speaker at national and international meetings. After receiving her Medical Doctorate at Chicago Medical School, Dr. Esmaeli completed her Ophthalmology Residency at the University of Michigan in 1994. Shortly following, she completed the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Fellowship in Ophthalmic Plastic and Reconstructive Surgery at the University of Toronto. In 1998, Dr. Esmaeli began her orbital oncology and oncologic ophthalmic plastic surgery practice at MD Anderson Cancer Center in Houston, Texas. Her research interests include early detection of metastasis, multi-disciplinary eye sparing approaches, and molecular targets for treatment for ocular and orbital cancers. For her work, Dr. Esmaeli has received many prestigious awards and honors including the Merrill Reeh Pathology Award and the Research Award from the American Society of Ophthalmic Plastic and Reconstructive Surgery, the American Academy of Ophthalmology Senior Achievement Award, Best Doctors in America, and Top Doctors Award. In 2017 and 2018, Dr. Esmaeli had two of her articles which were published in the peer-reviewed scientific journal Cancer Cell included on the Wall of Science at MD Anderson Cancer Center.
Sachin Salvi
Mr Sachin Salvi is Consultant Ophthalmologist and Clinical Lead of the Sheffield Ocular Oncology Service, Orbital and Oculoplastic Surgery Services at the Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust. He is an internationally recognised, award-winning surgeon specialising in ocular oncology, orbital and oculoplastic surgery. Mr Salvi trained in India, the UK and the USA, completing fellowships at the Royal Hallamshire Hospital, Sheffield; Moorfields Eye Hospital, London; and the Cole Eye Institute, Cleveland Clinic. He holds qualifications including MBBS, DOMS, FCPS, DipNB, FRCS(Glasg) and FRCOphth. He is MDT Lead at the National Sheffield Ocular Oncology Service, one of only three designated ocular oncology centres in England, and is among a select group of UK ophthalmologists managing the full spectrum of adult ophthalmic oncology, including eyelid, conjunctival, intraocular and orbital tumours. Mr Salvi played a key role in developing the NICE-accredited national guidelines on uveal melanoma. He is Director of the Fellowship Training Programme in Ocular Oncology, Oculoplastics and Orbital Surgery, and is actively involved in clinical research and the training of the next generation of ophthalmologists.